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Abstract
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Synthetic hydrogel scaffolds that can be used as culture systems that mimic the natural stem cell
niche are of increased importance for stem cell biology and regenerative medicine. These artificial
niches can be utilized to control the stem cell fate and will have potential applications for
expanding/differentiating stem cells in vitro, delivering stem cells in vivo, as well as making tissue
constructs. In this study, we synthesized hyaluronic acid (HA) hydrogels that could be degraded
through a combination of cell-released enzymes and used them to culture mouse mesenchymal
stem cells (mMSC). To form the hydrogels, HA was modified to contain acrylate groups and
crosslinked through Michael addition chemistry using non-degradable, plasmin degradable or
matrix metalloproteinase (MMP) degradable crosslinkers. Using this hydrogel we found that
mMSC proliferation occurred in the absence of cell spreading, that mMSCs could only spread
when both RGD and MMP degradation sites were present in the hydrogel and that mMSCs in
hydrogels with high density of RGD (1000µM) spread and migrated faster and more extensively
than in hydrogels with low density of RGD (100µM).

Introduction
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Stem cells have the ability to self-renew and differentiate into a wide range of specialized
cell types. Thus, they are very promising for the regeneration of aged, injured and diseased
tissues [1–3]. Embryonic stem cells (ESC), induced pluripotent stem cells (iPS), and adult
stem cells are currently the primary cell source for research in the lab and clinic. ESCs,
which are derived from the inner cell mass of early stage embryos, can be differentiated into
most of the cell types found in the body and can be expanded in vitro [4–6]. iPS cells are
generated by reprogramming specialized cells (eg. fibroblast) to the pluripotent state through
the addition of specific transcription factors (eg. Oct-3/4, SOX2, c-Myc, and Klf4). This
results in cells that exhibit similar characteristics to ESCs [7–11]. Adult stem cells are
extracted from adult tissues and can only be differentiated into limited cell types [12,13]. To
successfully apply stem cells in clinics, there are many technical hurdles that need to be
solved [14]. Current systems aimed at efficiently expanding and generating pure, pluripotent
cells are lacking [15–23]. Furthermore, it is inefficient to differentiate them to a specific
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linage in vitro. It is difficult to expand adult stem cells in vitro without losing their ability to
differentiate [24]. The harsh microenvironments at the disease sites usually leads to low
stem cell survival rates and poor integration into the surrounding tissue [25].
Hydrogel-based synthetic 3D culture systems may provide a solution to these welldocumented problems [24,26,27]. In vivo, stem cells reside in complicated and dynamic 3D
microenvironments (stem cell niches) that are composed of extracellular matrix (ECM),
soluble/tethered protein factors and supporting cells. This niche provides biophysical and
biochemical cues that result in either a self-renewing homeostatic state or a state of cell
expansion and differentiation to repair injured tissue [28–30]. Thus synthetic 3D culture
systems that mimic stem cell niches can be utilized to control the stem cell fates and will
have potential applications for expanding / differentiating stem cells in vitro, delivering stem
cells in vivo, as well as making tissue constructs.
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Hyaluronic acid (HA), an anionic, non-sulfated glycoaminoglycan and major component of
the ECM, is widely distributed in connective, epithelial and neural tissue [31]. HA interacts
with a number of cell surface receptors, such as CD44, RHAMM (receptor for HA-mediated
motility) and ICAM-1(intercellular adhesion molecule 1) and contributes to tissue
hydrodynamics, cell proliferation and migration [32,33]. Due to its high biocompatibility
and low immunogenicity, HA is gaining popularity as a biomaterial for tissue engineering
and tissue regeneration [34–37]. Functional groups, such as thiols, acrylates, amines, can be
conjugated to the HA backbone through mild chemistries and further used as crosslinking
sites to form hydrogels as scaffolds for cells in vitro and in vivo [38,39]. Several studies
have demonstrated that HA-based hydrogels are good candidates for culturing stem cells
[40–44]. In this study, we cultured mMSCs in HA hydrogels, which were degradable by
hyaluronidases alone or a combination of hyaluronidase and plasmin or hyaluronidases and
matrix metalloproteinases. We investigated the role of these different conditions on the
ability of mMSCs to spread, migrate and proliferate. Furthermore, we studied the effect of
the hydrogel mechanical properties and RGD concentration on migration and proliferation
rates as well as the extent of cell spreading.

Methods
Materials
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Peptides GCREG-PQGIWGQ-ERCG (HS-MMP-SH), GCRE-NRV-ERCG (HS-PlasminSH) and Ac-GCGYG-RGDSPG-NH2 (RGD) were purchased from Genscript (Piscataway,
NJ). Bovine plasma thrombin and human fibrinogen (plasminogen depleted) were bought
from Sigma-Aldrich (St. Louis, MO) and Enzyme Research Laboratories (South Bend, IN),
respectively. Sodium hyaluronan (HA) was a gift from Genzyme Corporation (60 KDa MW,
Cambridge, MA). All other chemicals were purchased from Fisher Scientific (Pittsburgh,
PA) unless otherwise noted.
Cell culture
Mouse bone marrow cloned mesenchymal stem cells (D1, CRL12424) were purchased from
ATCC (Manassas, VA) and cultured in DMEM (Sigma-Aldrich) supplemented with 10%
bovine growth serum (BGS, Hyclone, Logan, Utah) and 1% penicillin/streptomycin
(Invitrogen, Grand Island, NY) at 37 °C and 5% CO2. The cells were passaged using
standard protocols.
Modification of hyaluronic acid
Acrylated hyaluronic acid (HA-AC) was prepared using a two-step synthesis (Scheme 1A).
Hyaluronic acid (1.0g, 0.017mmole, 60kDa) was reacted with 18.0 g (105.5mmole) adipic
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dihydrazide (ADH) at pH 4.75 in the presence of 2.0g (10.41mmole) 1-ethyl-3-[3dimethylaminopropyl] carbodiimide hydrochloride (EDC) overnight and purified through
dialysis (8000 MWCO) in DI water for 1 week. The purified intermediate (HA-ADH) was
lyophilized and stored at −20°C until used. 38.8% of the carboxyl groups were modified
with ADH based on the trinitrobenzene sulfonic acid (TNBSA, Pierce, Rockford, Illinois)
assay. HA-ADH (1.0g, 0.014mmole) was reacted with N-Acryloxysuccinimide (NHSAC)
(0.75g, 4.4mmole) in HEPES buffer (pH 7.2) overnight and purified through dialysis in DI
water for 1 week before lyophilization. All the primary amines were acrylated based on the
TNBSA assay.
Preparation and characterization of HA hydrogels
HA hydrogels were formed by Michael Addition of bis-cysteine containing peptide
crosslinker or DTT onto HA-AC pre-functionalized with cell adhesion peptides (RGD
peptides) (Scheme 1B). Lyophilized aliquots of the crosslinker were diluted in 10 µL of 0.3
M TEOA (pH=8.0) buffer immediately before mixing with 90 µL HA-AC solution in 0.3 M
TEOA with or without cells. The gel precursor solution was then placed between two Teflon
plates for 30-min at 37 °C to allow for gelation. The final gel was swelled in DMEM before
being placed inside 96-well plates for long-term culture or other tests.
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The storage and loss modulus were measured with a plate-to-plate rheometer (Physica MCR,
Anton Paar, Ashland, VA) using a 8mm plate under a constant strain of 0.05 and frequency
ranging from 0.1 to 10 rad/s. Hydrogels were made as detailed above and cut to a size of
8.0mm in diameter to fit the plate. A humid hood was used to prevent the hydrogel from
drying and the temperature was kept at 25°C.
Encapsulation of cells in 3D HA hydrogels
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Cells were encapsulated into the 3D HA hydrogels using two protocols: homogeneous
encapsulation, resulting in single cells throughout the hydrogel, and clustered encapsulation,
resulting in a single cluster of cells inside a fibrin gel clot. The hydrogels containing
homogeneously encapsulated cells were used to study cell proliferation and spreading while
the cluster containing hydrogels were used to study cell migration. For the homogeneous
encapsulation, 500,000 cells were mixed with 100 µL gel precursor solution before gelation.
Cell clusters in fibrin gel clots were made by resuspending 150,000 D1 cells in 5 µL of
fibrin and thrombin solution (2 mg/mL fibrinogen and 2 U/mL thrombin). The clusters were
made by dropping the suspension onto a Teflon plate and incubating at 37 °C for 20 min.
The clusters were incorporated into the HA gel by placing them inside the gel precursor
solution. The gel was swelled in DMEM for two hours and cultured in DMEM
supplemented with 10% BGS and 1% P/S. At the indicated time points, cells were imaged
with an inverted microscope (Observer Z1, Zeiss) to record the phase pictures. These images
were analyzed to quantify cell migration out of the fibrin clot. The distance from the edge of
the fibrin clot to the leading edge of cell migration was measured for ~10–15 points per clotcontaining hydrogel and averaged. Please note that the migration rate also depends on the
water content of the fibrin clot. More water removal during the clot formation process
results in a tighter clot and a slower migration rate. The clots in each experimental group
were made in a similar manner and can be compared. However, only trends can be
compared between each experiment and not the absolute values.
Cell viability in the HA gels with homogenously encapsulated cells was studied with the
LIVE/DEAD® viability/cytotoxicity kit (Molecular Probes, Eugene, OR). Briefly, 1 µL of
ethidium homodimer-1 and 0.25 µL of calcein AM from the kit were diluted with 500 µL
DMEM without phenol red to. Each gel was stained with 150 µL of this staining solution for
30-min at room temperature in the dark and imaged with a confocal microscope (Leica TCS
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SP MP) or an inverted fluorescence microscope (Zeiss Axio Observer). For confocal images
10 pictures were taken for a gel section with 10 µm thickness and the average of the pictures
was presented. The Alamar Blue (Invitrogen) assay was used to quantify the cell
proliferation rate inside the hydrogels. 20 µL of alamar blue dye was mixed with 100 µL
phenol red free DMEM and added to each gel-containing well and incubated at 37 °C for 4
hrs. The proliferation ra tes were presented as fold increase over the value obtain after the
first day of culture.

Results
Hydrogel preparation and characterization
Acrylates were conjugated onto the HA backbone through a two-step process (Scheme 1A).
TNBSA assay results show that 38.8% of the –COOHs were coupled with ADHs. After
reacting the HA-ADH with NHS-AC at pH 7.2 overnight, TNBSA assay showed that no
free primary amines were detected for the final products, resulting in approximately 61
acrylates per HA chain.
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RGD adhesion peptides were incorporated through Michael addition of the cysteine side
chain in the peptide to the acrylate groups on the HA backbone. The cross-linker was then
added to form the hydrogels (Scheme 1B). The storage (G') and loss modulus (G") were
measured with a plate-to-plate rheometer. Results showing that the G' and G" did not cross
at any measured frequency (0.1 to 10 Hz) and frequency independence (Fig. 1A, B) were
consistent with typical hydrogel characteristics. The loss tangent values (ratio of G" to G')
were lower than 0.06 for all hydrogels tested, indicating that the hydrogels were highly
elastic. The mechanical properties of the hydrogels can be controlled by changing the HA
concentration or the crosslinking density, “r”, which is defined as moles of –SH from the
crosslinkers over moles of –ACs from the HA-ACs (Fig. 1C). The crosslinking density
changed the mechanical property moderately. For 3% HA gels, the G' at r = 0.25, 0.4 and
0.5 was 177.1 ± 0.5, 305.4 ± 1.8, and 387.4 ± 1.9 Pa, respectively. The HA concentration
had a larger effect on G’. At r = 0.25, the G' for 3, 4 and 5% gels was 177.1 ± 0.5, 817.7 ±
16.5 and 1920.0 ± 12.1 Pa, respectively.
Effect of the crosslinker type
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The effect of crosslinker type on mMSC spreading, proliferation and migration was studied
using three different crosslinkers: a non-degradable crosslinker, DTT, a plasmin degradable
crosslinker, HS-Plasmin-SH [45], and a MMP degradable crosslinler, HS-MMP-SH [27].
Two RGD concentrations (100 and 1000 µM) were tested for each crosslinker. Live/Dead
cell staining was performed to assess the cell viability inside the hydrogels immediately after
gel formation (data not shown) and 3 days after culturing the cells in the gels (Fig. 2A–F).
The sparse number of dead cells indicate that the chemistry and the chemicals for making
the gels were non-lethal to cells. Cells in hydrogels crosslinked with DTT (HA/DTT
hydrogel) and HS-Plasmin-SH (HA/Plasmin hydrogel) maintained spherical morphologies
without spreading through the entire course of the experiment (Fig. 2A–D), while cells in
hydrogels formed with HS-MMP-SH (HA/MMP hydrogel) exhibited spindle-like
morphologies and extensive spreading (Fig. 2E, F). There were no significant differences in
spreading and survival observed between the two RGD concentrations for all the
crosslinkers.
A fibrin/cell clot was placed in the hydrogel to test if the hydrogel was able to support cell
migration and which crosslinker resulted in the fastest migration. No migration was
observed in HA/DTT and HA/Plasmin hydrogels regardless of the RGD concentration used
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(Fig. 2G–J). Cells migration was seen when the mMSCs cultured in HA-MMP hydrogels,
with faster migrations observed in the gel with 1000 µM RGD (Fig. 2K, L).
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Alamar blue assay was utilized to evaluate if the crosslinkers affect the cell proliferation for
cells cultured inside the hydrogels. The proliferation rate of cells in HA/DTT hydrogels was
slower than those for HA/plasmin and HA/MMP hydrogels. However, the cells did
proliferate through the first 3 days of culture. The proliferation rate of the cells in HAPlasmin hydrogels climbed from day 1 to day 2 before hitting a plateau, whereas the
proliferation rate of the cells in HA-MMP hydrogels increased throughout the culture. HAMMP hydrogels were chosen for the remaining of the study.
Effect of RGD concentration
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RGD peptides, which are ligands for integrin receptors, were introduced as adhesion points
in the gels. Though cells were alive throughout the culture as shown by the absence of dead
cells through the live/dead cell staining, they were unable to spread and maintained spherical
morphologies in the HA-MMP hydrogels without RGD (Fig. S1 and 3A, RGD 0 µM).
Though no influence on the cell viability was observed, introducing RGD significantly
changed the cell morphology to exhibit spindle-like morphologies (Fig. S1 and 3A, RGD
100 to 1000 µM). The RGD concentration influenced both the starting time and the extent of
cell spreading. Few cells were spreading after 1-day of culture (referred as Day 1 for the rest
of the paper) and large percentage of cells remained spherical at after 3-days of culture
inside the hydrogels with low RGD concentrations (Fig. S1 and 3A, RGD 100, 250 µM).
While the majority of cells were spreading at day 1 inside the hydrogels with high RGD
concentrations (Fig. S1 and 3A, RGD 750, 1000 µM), it was difficult to quantify the extent
of spreading. However, it was generally observed that cells were much longer and extended
in hydrogels with more RGD.
RGD concentration affected the cell proliferation as well, with low RGD concentration
resulting in enhanced proliferation (Fig. 3B, RGD 100 and 250 µM) than with high RGD
concentrations (Fig. 3B, RGD 500, 750 and 1000 µM). Surprisingly, cells in the hydrogel
without RGD proliferated as well as the gels with low RGD concentrations (Fig. 3B). We
further tested if RGD concentration was an important factor to modulate cell migration in
HA hydrogels. Cells failed to migrate without RGD (Fig. 3C, RGD 0 µM), while they
migrated in the hydrogels with RGD (Fig. 3C, RGD 100–1000 µM). The migration rates in
HA hydrogels (3% HA, r = 0.4) with 0, 100, 250, 500, 750 and 1000 µM RGD were 0, 55,
68, 77, 72 and 87 µm/day, respectively (Fig. 3D). Generally, high RGD concentrations
promoted faster cell migration.
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Effect of HA concentration
We tested if cells spread, proliferate and migrate differently in hydrogels with different HA
concentrations. HA hydrogels with 3, 4 and 5 HA-% and either 100 or 1000 µM RGD were
used. Cells were alive in all the hydrogels as shown by the Live/Dead staining (Fig. 4A).
With 100 µM RGD, only the cells in the 3% HA spread, as indicated by the spindle-like
morphologies inside the 3% hydrogel and the spherical morphologies inside the 4 and 5%
gels. With 1000 µM RGD, cells in 3% and 4% HA exhibited spindle-like morphologies,
while cells in the 5% HA stayed spherical (Fig. S2 and 4A). The proliferation rates of cells
in 3, 4, and 5% HA hydrogels with 100 µM RGD all increased during the culture. However,
cells proliferated slower at higher HA concentrations (Fig. 4B).
High HA concentration inhibited cell migration (Fig. 4C) as hydrogels with 100 µM RGD in
3, 4 and 5% HA had migration rates of 95, 50 and 0 µm/day respectively. With 1000 µM
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RGD, the migration rates increased to 88 and 35 µm/day in the 4 and 5% HA gels, but only
slightly affected the migration rate in the 3% HA gel (99 µm/day) (Fig. 4D).
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Discussion

We tested if the crosslinking density influenced the D1 cells in the gels. HA-MMP
hydrogels (3% HA) at r = 0.25, 0.4 and 0.5 in the presence of 100 and 1000 µM RGD were
prepared. Cells were viable in all the hydrogels as shown by the Live/Dead cell staining
(Fig. 5A). Increasing the crosslinking density inhibited cell spreading. At 100 µM RGD the
majority of cells exhibiting spherical morphologies in the r = 0.4 and 0.5 hydrogels. Raising
the RGD concentration to 1000 µM led to cell spreading in all the hydrogels (Fig. S3 and
5A). The proliferation rates of cells in 3% HA at r = 0.25 and 0.4 increased during the
culture, while for r = 0.5 proliferation plateau after the second day of culture (Fig. 5B).
The cell migration rate was extensive for all the crosslinking ratios tested (Fig. 5C). The
migration rates were higher for the lowest crosslinking ratio used for both 100 µM and 1000
µM with migration rates of 220 µm/day and 240µm/day, respectively (Fig. 5D). For r = 0.4
the migration rates were 220 µm/day and 160 µm/day for 100 and 1000µm/day respectively
and for r = 0.5 the migration rates were 210 µm/day and 160 µm/day respectively for 100
and 1000 µM RGD respectively (Fig. 5D).

The natural ECM is an extremely dynamic network that consists of protein fibers and
polysaccharides that support cell fate and provide biophysical and biochemical cues to cells
through cell surface receptors, such as integrins [46,47]. Cells degrade the ECM through
proteases during their migration. Synthetic ECM hydrogels that aim to provide an
environment to direct stem cell fate should recapitulate key features of the natural ECM
such as integrin mediated cell binding, cell migration, and cell proliferation, while also
allowing for soluble factor diffusion to the encapsulated cells. Here HA was crosslinked
with DTT or peptides using Michael addition chemistry to form hydrogels that were
degradable exclusively through hyaluronidases or through a combination of hyaluronidases
and plasmin or hyaluronidases and MMPs. In addition, the HA backbone was modified with
RGD peptides to introduce integrin binding sites.
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HA hydrogels were formed through the reaction of acrylate groups in the HA backbone and
thiols at the ends of DTT or peptide crosslinkers. Acrylate groups were introduced to the HA
backbone using a two-step synthetic scheme (Scheme 1A), which resulted in
approximatedly 61 acrylates per HA chain (38% modification). This large number of
acrylates per chain brings two advantages over 4 or 8-arm PEG based systems. First, since
only 10% percent of acrylates are needed to form a hydrogel, it allows the other 90% of
acrylate groups to be used to incorporate bioactive signals, such as adhesion peptides and
protein growth factors without compromising hydrogel formation. Second, it enables a wide
range of crosslinking densities without changing the percent of HA used. In these
experiments we used 3% HA w/v and incorporated up to 1000µM RGD.
Cell spreading and migration inside hydrogels required that the cells be able to displace the
polymer chains or degrade them in order to make space for their movement. Hyaluronic acid
hydrogels are attractive tissue engineering scaffolds because the backbone is completely
degradable by cell release hyaluronidases. In order to determine if degradation by
hyaluronidases was sufficient to allow mMSC spreading, proliferation and migration in
vitro, HA was crosslinked with DTT, a non-degradable crosslinker (Fig 2). Although cells
inside HA/DTT hydrogels fail to spread or migrate, LIVE/DEAD staining and proliferation
assays demonstrated that the cells were viable and able to proliferate. These results indicate
Biomaterials. Author manuscript; available in PMC 2012 January 1.
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that hyaluronidases released by mMSCs alone cannot promote spreading or migration;
extensive matrix degradation was not needed for proliferation or keeping the cells alive.
These results agree with previous reports that show viable cells in MMP insensitive HA
hydrogels with or without RGD peptide [43]. HA crosslinked with a plasmin degradable
crosslinker also resulted in no cell spreading or migration, indicating that mMSCs do not
produce significant amounts of plasmin to allow cell migration or spreading. However, the
cells were viable and able to proliferate. These results differ from those regarding fibroblast
culture inside plasmin degradable PEG hydrogels, in which spreading and migration was
observed [48]. Our results further confirm that extensive matrix degradation is not required
for viability or proliferation. MMP degradable HA hydrogels resulted in significant cell
spreading, proliferation and migration for both 100µM and 1000µM RGD concentration.
These results agree with previously reports that show mMSC [49] and fibroblast [48] cell
spreading and proliferation in MMP degradable HA and PEG hydrogels, respectively.
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Integrin mediated cell-matrix interactions were necessary for cell spreading as showed by
the lack of spreading and migration of the cells in HA-MMP gels without RGD (Fig. 3). In
general, higher concentration of adhesion peptides in the gels corresponds to stronger cellmatrix interactions [50]. Stronger cell-matrix interactions lead to cells spreading earlier,
more extensively and migrating faster as demonstrated by the earlier start spreading time,
longer morphologies and faster migration rates in the presence of 1000 µM RGD (Fig. 3C,
D). These findings are similar to previously published reports that show extensive spreading
for higher concentration RGD in PEG hydrogels [51].
Cell-matrix interactions affected cell proliferation differently than that observed for
spreading and migration. Cells cultured inside hydrogels with low RGD concentration
proliferated more than cells cultured inside hydrogels with high concentration of RGD (Fig.
3B). These results agree with previous results that showed that bone marrow stroma cells
proliferated at the same rate inside PEG or HA hydrogels with or without RGD peptide
modification [43,52].
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The ability of mMSCs to spread, proliferate and migrate in HA/MMP hydrogels with
different mechanical properties was studied using different crosslinking ratios, while
keeping the HA concentration constant or by changing the HA concentration, while keeping
the crosslinking ratio constant. The resulting hydrogels ranged in storage modulus from 177
to 387 Pa for 3% gels formed with different crosslinking ratios and 177 to 1919 Pa for
different HA concentrations, which cover the mechanical properties of the soft tissues in the
body (Fig. 1) [54]. Changes in mechanical properties from 177 to 387 Pa did not result in
changes in spreading for high concentrations of RGD (1000 µM, Fig. 5). However, cell
spreading was inhibited in 387 Pa hydrogels, which contained 100 µM RGD, indicating that
the density of integrin binding sites can overcome spreading limitations in stiffer higher
crosslinked materials. In general, migration was faster for cells seeded in lower crosslinked
hydrogels (softer). Increasing the HA concentration from 3% to 4% in the presence of 100
µM RGD stopped cell spreading, inhibited the cell migration and slowed down proliferation
(Fig. 4). Similarly to our findings with different crosslinking ratios, increasing the RGD
concentration to 1000 µM facilitated cell spreading and migration for 4% hydrogels (816
Pa). However, for 5% hydrogels (1919 Pa) no spreading or migration was observed and
proliferation was significantly lower than for softer hydrogels.
Mechanical properties have been shown to strongly modulate stem cell fate [55]. For cells
cultured inside hydrogel scaffolds with elastic modulus of 11–30 kPa and 2.5–5 kPa lead
mMSCs commit to osteogenic and adipogenic lineages, respectively [50]. Further, MSCs,
seeded in two dimensions, can be differentiated into neuron, myoblast, osteoblast lineages
by using substrates with compliances close to the brain, muscle and bone tissues,
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respectively [54]. Thus hydrogels with a wide range of mechanical properties, such as the
ones reported, are ideal to study stem cell differentiation potential.
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Conclusion
HA hydrogels were developed for 3D culture of stem cells. The effects of the hydrogel
properties on mMSC proliferation, spreading and migration were studied. Variable
parameters include: crosslinker type, concentration of adhesion peptide (RGD), HA
concentration, and crosslinking density. Degradation of the scaffold via MMPs was required
for cell spreading and migration, but not for cell proliferation. Introducing the RGD
adhesion peptides into the hydrogel enabled the cells to interact with the scaffold and was
crucial for cell spreading and migration. In general, cells spread earlier, more extensively
and migrated faster in the presence of high concentration of RGD. However, cells in
hydrogels with low concentration of RGD exhibited high proliferation rates. The mechanical
properties of the hydrogels, which could be controlled through changing the HA
concentration or crosslinking density, influenced the cell behavior as well. Cells in stiffer
hydrogels showed less spreading, migration and slower proliferation rates. The information
gained can provide valuable insight into the designing of hydrogels for 3D stem culture.
Additionally, the hydrogel developed in this study can be used as a platform for developing
synthetic niches for various stem cells in the future.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.

The storage (G') and loss modulus (G") of HA-MMP hydrogels. (A) 3% HA hydrogels with
various crosslinking densities (r = 0.25, 0.4, 0.5). (B) 3%, 4%, 5% HA hydrogels at r = 0.25.
The modulus were measured with a rheometer at constant strain of 0.05 with frequency
ranging from 0.1 to 10 rad/s. The average of G' and G" over the frequency range were
shown in (C)
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Figure 2.

Effect of crosslinker identity on D1 cells in HA hydrogels. (A–F) Cell viability at day 3
(green: live cell; red: dead cell). (G–L) Cell migration from fibrin/cell clot into hydrogels.
Snapshots were taken at day 3. The dash lines highlight the edges of the clots. “C” refers to
fibrin/cell clot. (M) Proliferation rates of cells in hydrogels with 100 µM RGD. Crosslinker:
DTT for (A, B, G, H); HS-Plasmin-SH for (C, D, I, J); HS-MMP-SH for (E, F, K, L). RGD
concentration: 100 µM for (A, C, E, G, I, K); 1000 µM for (B, D, F, H, J, L). Scale bar: 100
µm. 3.5% HA and r = 0.4 for all gels
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Figure 3.

Effect of RGD concentration on D1 cells in HA-MMP hydrogels. (A) Cell viability and
spreading at day 3 (green: live cell; red: dead cell). (B) Proliferation rates. (C) Cell
migration at day 5. The dash lines highlight the edges of the clots. “C” refers to fibrin/cell
clot. (D) Migration rates were 0, 55, 68, 77, 72 and 87 µm/day for cells in the gels with 0,
100, 250, 500, 750 and 1000 µM RGD respectively. Scale bars for (A) and (C) are 200 and
100 µm, respectively. 3% HA and r = 0.4 for all gels
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Figure 4.

Effect of HA concentration on D1 cells in HA-MMP hydrogels. (A) Cell viability and
spreading at day 2 (green: live cell; red: dead cell). (B) Proliferation rates of cells in 3%, 4%
and 5% HA gels with 100 µM RGD. (C) Cell migration. Snapshots were taken at day 6. The
dash lines highlight the edges of the clots. “C” refers to the fibrin/cell clot (D) Migration
rates were 95, 50, 0 µm/day in 3%, 4%, 5% hydrogels with 100 µM RGD (open symbols)
and were 99, 88, 2 µm/day in 3%, 4%, 5% hydrogels with 1000 µM RGD (filled symbols),
respectively. Scale bars for (A) and (C) are 200 and 100 µm, respectively. r = 0.25 for all
gels.
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Figure 5.

Effect of crosslinking density on D1 cells inside HA-MMP hydrogels. (A) Cell viability and
spreading at day 2 (green: live cell; red: dead cell). (B) Proliferation rates of cells in
hydrogels with 100 µM RGD. (C) Cell migration. Snapshots were taken at day 3. The dash
lines highlight the edges of the clots. “C” refers to the fibrin/cell clot (D) Migration rates
were 220, 220, 210 µm/day in hydrogels at r = 0.25, 0.4, 0.5 at 100 µM RGD (open
symbols) and were 240, 160, 160 µm/day hydrogels at r = 0.25, 0.4, 0.5 at 1000 µM RGD
(filled symbols), respectively. Scale bars for (A) and (C) are 200 and 100 µm, respectively.
3% HA for all gels
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Scheme 1.

(A) Synthesis of HA-AC and (B) Making HA hydrogels through Michael Addition
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